SecBot SecBot
COURT-RULING ·Filed Mar 2, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed4mo ago CourtCourt Ruling · courtlistener.com
Court ruling (district)
Actionable Insight • Neutral

This ruling allows discovery to proceed on Vytorin-related antitrust claims but does not change the fundamental risk profile for Merck. The case remains in early stages; monitor for future dispositive motions or settlement developments. No immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$119.83
T+0 close · Mar 3, 2026 · via day close
Latest settled
+0.05%
T+60 · $119.89
Vs SPY
−10.87%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 3 $119.83entry
  2. T+1 · 9mo ago +0.38%α −0.33% · $120.28
  3. T+5 · 8mo ago −2.29%α −1.82% · $117.09
  4. T+20 · 8mo ago +0.38%α +4.79% · $120.29
  5. T+60 · 6mo ago +0.05%α −10.87% · $119.89
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The court granted in part Kaiser's request to take additional depositions of Merck (including a 30(b)(6) deposition on Vytorin-related topics and two former employees) after remand from the Zetia MDL, but denied two topics related to Orange Book patent listings. This is a routine procedural discovery order that does not resolve any substantive claims or impose financial liability.

Court Ruling Details

Ruling Date
Mar 2, 2026
Court
United States District Court for the Northern District of California
Court Level
District
Judge
Lisa J. Cisneros
Case Type
antitrust
Ruling Type
discovery
Outcome
PARTIAL: mixed ruling, some claims won/lost
Precedent Risk
LOW

Key Facts

  • Kaiser may take a 30(b)(6) deposition of Merck on 8 of 10 proposed topics related to Vytorin pricing, marketing, and strategy
  • Kaiser may depose two former Merck employees (Glen Firestone and Paul McCrorey) as fact witnesses
  • Two topics regarding Orange Book listings of the '966 and '106 patents were denied without prejudice
  • The court found the Vytorin claims are substantially different from the Zetia claims that were the focus of the MDL
  • No damages, injunction, or liability determination was made

Financial Impact

No financial impact; this is a procedural discovery ruling with no monetary award or business restriction

Risk Factors

  • Continued litigation could lead to future adverse rulings or settlement costs if antitrust claims survive summary judgment
  • Discovery may uncover additional evidence that strengthens Kaiser's case

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
69% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-wr3becz2-MRK

Track record

34 reports on MRK

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.92% at T+20 after the Aug 6, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 12, 20264d ago 144 Neutral 2/10 Entry $147.76 Now $144.46 −2.23% settles Feb 11
  2. Nov 9, 20268d ago PTAB Trial Neutral 2/10 Entry $148.05 Now $144.46 −2.42% settles Feb 8
  3. Nov 3, 202613d ago 3 Neutral 2/10 Entry $144.67 Now $144.46 −0.15% settles Feb 1
  4. Nov 3, 202613d ago Institutional Cluster Bearish 4/10 Entry $144.67 Now $144.46 +0.15% settles Feb 1
  5. Nov 2, 202614d ago 144 Neutral 2/10 Entry $144.67 Now $144.46 −0.15% settles Feb 1
  6. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $146.33 Now $144.46 −1.28% settles Jan 27
  7. Oct 22, 202625d ago 3/A Neutral 1/10 Entry $145.27 Now $144.46 −0.56% settles Jan 21
  8. Oct 21, 202627d ago PTAB Trial Neutral 3/10 Entry $147.24 Now $144.46 −1.89% settles Jan 20
  9. Oct 15, 20264w ago PTAB Trial Bullish 6/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
  10. Oct 15, 20264w ago PTAB Trial Bullish 5/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (10h 9m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published Jul 4, 2026